ResearcherUniversity of Nebraska Medical CenterNo recent work listed
Ramakanth Chirravuri‐Venkata
Matched on ORCID iD 0000-0003-2273-0795; OpenAlex author ID A5060348308. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 42
2021: 1 paper · 2022: 4 papers · 2023: 1 paper
Papers 6
- MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1073820↗
- Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2022.215922↗
- Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
- Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02493-6↗
- Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/metabo12010047↗
- Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-020-01564-w↗
Closest collaborators
The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 6 shared papers, 2021–2023 · strength 0.76
- Paper MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. DOI 10.3389/fonc.2023.1073820↗
- Paper Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. DOI 10.3390/metabo12010047↗
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Rama Krishna Nimmakayala · 5 shared papers, 2021–2023 · strength 0.62
- Paper MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. DOI 10.3389/fonc.2023.1073820↗
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2021–2023 · strength 0.62
- Paper MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. DOI 10.3389/fonc.2023.1073820↗
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Maneesh Jain · 4 shared papers, 2021–2023 · strength 0.50
- Paper MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. DOI 10.3389/fonc.2023.1073820↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Satyanarayana Rachagani · 4 shared papers, 2021–2022 · strength 0.47
- Paper Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. DOI 10.3390/metabo12010047↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Lynette M. Smith · 4 shared papers, 2021–2022 · strength 0.44
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Parthasarathy Seshacharyulu · 4 shared papers, 2021–2022 · strength 0.44
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Sushil Kumar K · 3 shared papers, 2022–2023 · strength 0.40
- Paper MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. DOI 10.3389/fonc.2023.1073820↗
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Kavita B. Mallya · 3 shared papers, 2021–2022 · strength 0.36
- Paper Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. DOI 10.3390/metabo12010047↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. DOI 10.1038/s41388-020-01564-w↗
- Pranita Atri · 3 shared papers, 2022 · strength 0.34
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Sanchita Rauth · 3 shared papers, 2021–2022 · strength 0.34
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. DOI 10.1038/s41388-020-01564-w↗
- Namita Bhyravbhatla · 2 shared papers, 2022–2023 · strength 0.28
- Imayavaramban Lakshmanan · 2 shared papers, 2022–2023 · strength 0.28
- Seema C. Parte · 2 shared papers, 2022 · strength 0.23
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Ashu Shah · 2 shared papers, 2022 · strength 0.23
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Saravanakumar Marimuthu · 2 shared papers, 2022 · strength 0.23
- Paper Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic duct… DOI 10.1016/j.canlet.2022.215922↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Palanisamy Nallasamy · 2 shared papers, 2021–2022 · strength 0.23
- Sanjib Chaudhary · 2 shared papers, 2022 · strength 0.22
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Geoffrey A. Talmon · 2 shared papers, 2022 · strength 0.22
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Shailendra Kumar Gautam · 2 shared papers, 2022 · strength 0.22
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Zahraa Wajih Alsafwani · 1 shared paper, 2023 · strength 0.17
- Venugopal Gunda · 1 shared paper, 2022 · strength 0.15
- Jyoti Kaushal · 1 shared paper, 2022 · strength 0.15
- Paul M. Grandgenett · 1 shared paper, 2022 · strength 0.15
- Rakesh C. Kukreja · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.